Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Brainstorm Cell Theraputc (BCLI)

Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 9,821
  • Shares Outstanding, K 11,035
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,620 K
  • EBIT $ -11 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.69
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.21
  • Most Recent Earnings $-0.91 on 11/14/25
  • Next Earnings Date 03/30/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +195,982.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5950 +55.45%
on 02/26/26
0.9699 -4.64%
on 03/24/26
+0.3016 (+48.39%)
since 02/25/26
3-Month
0.4589 +101.55%
on 02/13/26
0.9699 -4.64%
on 03/24/26
+0.3349 (+56.76%)
since 12/24/25
52-Week
0.4589 +101.55%
on 02/13/26
1.9200 -51.83%
on 05/19/25
-0.5151 (-35.77%)
since 03/25/25

Most Recent Stories

More News
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February

NEW YORK , Feb. 26, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has...

BCLI : 0.9249 (+3.92%)
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market

NEW YORK , Feb. 20, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has...

BCLI : 0.9249 (+3.92%)
BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update

NEW YORK , Nov. 14, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial...

BCLI : 0.9249 (+3.92%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.9249 (+3.92%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.9249 (+3.92%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.9249 (+3.92%)
BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Conference call and webcast scheduled for 8:30 a.m. Eastern Time Today, Thursday, August 14, 2025

BCLI : 0.9249 (+3.92%)
BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update

Call Scheduled for August 14, 2025 , at 8:30 AM Eastern Time

BCLI : 0.9249 (+3.92%)
BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB

NEW YORK , July 17, 2025 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that it has received a delisting notification from The Nasdaq Stock Market LLC, informing the...

BCLI : 0.9249 (+3.92%)
News Movers: Yesterday’s Hottest News That Could Move the Needle Today

Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks

BCLI : 0.9249 (+3.92%)
LASE : 0.9733 (-6.41%)
PPBT : 4.09 (+3.15%)
BCTX : 4.08 (-0.49%)
STXS : 1.8500 (+2.78%)
DMGGF : 0.1734 (-1.76%)

Business Summary

BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.

See More

Key Turning Points

3rd Resistance Point 1.0532
2nd Resistance Point 1.0115
1st Resistance Point 0.9508
Last Price 0.9249
1st Support Level 0.8484
2nd Support Level 0.8067
3rd Support Level 0.7460

See More

52-Week High 1.9200
Fibonacci 61.8% 1.3619
Fibonacci 50% 1.1895
Fibonacci 38.2% 1.0170
Last Price 0.9249
52-Week Low 0.4589

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.